Description
Supplement First is an Authorized Retailer for Thorne Research.
- Thorne Research Advanced Bone Support (Formerly Oscap) contains more calcium, magnesium, and vitamin D per capsule than the previous formula.
- In addition, it provides B vitamins for healthy methylation, and boron – all to support bone health.*
- An advanced bone formula with calcium and vitamin D per capsule for added bone support*
Suggested Use:
Take 2 capsules two times daily or as recommended by your health-care practitioner.
Supplement Facts
| Serving Size: Two Capsules | Two Capsules Contain: | %DV |
| Vitamin D (as Vitamin D3) (1,000 IU) |
25 mcg | 125% |
| Vitamin B6 (as Pyridoxal 5′-Phosphate) |
20 mg | 1,176% |
|
Folate |
166.6 mcg DFE | 42% |
| Vitamin B12 (as Methylcobalamin) | 50 mcg | 2,083% |
| Calcium (as DimaCal® DiCalcium Malate)†† |
300 mg | 23% |
| Magnesium (as Albion® DiMagnesium Malate)††† |
100 mg | 24% |
| Boron (as Bororganic™ Boron Glycinate Complex)†††† |
3 mg | * |
*Daily Value (DV) not established.
Other Ingredients:
Hypromellose (derived from cellulose) capsule, medium chain tryglyceride oil.
Allergy Warning:
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.
Pregnancy:
If pregnant, consult your health-care practitioner before using this product.
Interactions:
5-methyltetrahydrofolate (5-MTHF) supplementation is not recommended concurrent with methotrexate cancer therapy, as it can interfere with methotrexate’s anti-neoplastic activity; however, this folate source has not been shown to interfere with the anti-inflammatory activity of methotrexate. An individual taking methotrexate for psoriasis or rheumatoid arthritis can safely take a supplement containing folate.
Tamper Evident:
Use only if bottle is sealed. Store tightly sealed in a cool, dry place.
*These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to treat, mitigate, diagnose or cure any disease.






Reviews
There are no reviews yet.